| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972813 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
Adding urokinase into the perfusate during ex vivo evaluation resulted in improved graft function by reducing pulmonary vascular resistance and increasing oxygenation after 3 hours of warm ischemia. This ex vivo evaluation model is feasible and may be used to recondition grafts from NHBDs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ilhan MD, Wei MD, Stephan PhD, Demet MD, Sven MD, Didier MD, Peter MD, Walter MD,